Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 94 | 15.2% |
| Current Price (11/20) | $140.65 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 2,077.2 | |||
| Sales Growth Forecast | 13.3% | |||
| Net Profit Margin | 45.7% | |||
| Projected Shares Outstanding | 61.87 | |||
| EPS - Five year Forecast | $28.59 | |||
| Average P/E Ratio | 10.0 | |||
| Projected Average Price | $285.95 | |||
| Price Appreciation (Annualized) | 15.2% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 15.2% | |||
| Quality | ||||
| Financial Strength | 85 | 21.3 | ||
| EPS Stability | 94 | 23.6 | ||
| Industry Sales Growth Rate | 16.5% | 10.0 | ||
| Industry Net Profit Margin | 29.0% | 19.7 | ||
| Calculated Quality Rating | 74.7 | |||
| Fool CAPS | ||||
Total Players
305
Outperforms
67
Underperforms
All-Stars (69)
54
Outperforms (78%)
15
Underperforms
|
||||
| Fundamental Data Updated: 09/06/2019 | ||||